While mice treated with either Panobinostat or Mocetinostat showed reduced xenograft tumor growth (Supplementary Fig. 16b), the expression of established invasiveness genes, such as AXL or NGFR was upregulated (Supplementary Fig. 16c). This evidence concerns the gene AXL and neoplasm.